Organigram Global Stock-Based Compensation Growth & History (OGI)

Organigram Global's stock-based compensation was $4.2M for fiscal 2025.

View full Organigram Global company overview

Organigram Global annual stock-based compensation history

Organigram Global annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-09-30$4.2M−$2.1M−32.79%
20242024-09-30$6.3M$1.0M+18.98%
20232023-09-30$5.3M
20222022-08-31$4.7M$1.5M+47.59%
20212021-08-31$3.2M−$1.5M−31.96%
20202020-08-31$4.7M−$4.4M−48.37%
20192019-08-31$9.2M$4.9M+116.44%
20182018-08-31$4.2M

Organigram Global stock-based compensation trends

Between the periods ended 2018-08-31 and 2025-09-30, Organigram Global's stock-based compensation decreased from $4.2M to $4.2M, a change of −$11,000. The latest reported quarter, Q3 2026, shows $1.2M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Organigram Global source filings ↗

Community posts

It’s quiet here.

No posts about OGI yet. Start the conversation.

Write the first post